On Tuesday, Roivant Sciences Ltd (NASDAQ: ROIV) was -0.29% drop from the session before settling in for the closing price of $10.52. A 52-week range for ROIV has been $9.76 – $13.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 493.24% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -109.23%. With a float of $442.59 million, this company’s outstanding shares have now reached $719.63 million.
In an organization with 908 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 89.03%, operating margin of -1027.4%, and the pretax margin is -594.75%.
Roivant Sciences Ltd (ROIV) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Roivant Sciences Ltd stocks. The insider ownership of Roivant Sciences Ltd is 37.97%, while institutional ownership is 68.69%. The most recent insider transaction that took place on Feb 20 ’25, was worth 1,065,000. In this transaction President & COO of this company sold 100,000 shares at a rate of $10.65, taking the stock ownership to the 896,869 shares. Before that another transaction happened on Feb 20 ’25, when Company’s Officer proposed sale 100,000 for $10.65, making the entire transaction worth $1,065,022.
Roivant Sciences Ltd (ROIV) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -109.23% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
You can see what Roivant Sciences Ltd (ROIV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 37.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 76.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.14, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.12 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Let’s dig in a bit further. During the last 5-days, its volume was 3.88 million. That was inferior than the volume of 4.22 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 32.42%. Additionally, its Average True Range was 0.28.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 6.32%, which indicates a significant decrease from 13.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.73% in the past 14 days, which was lower than the 28.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.21, while its 200-day Moving Average is $11.36. However, in the short run, Roivant Sciences Ltd’s stock first resistance to watch stands at $10.62. Second resistance stands at $10.76. The third major resistance level sits at $10.89. If the price goes on to break the first support level at $10.35, it is likely to go to the next support level at $10.22. The third support level lies at $10.08 if the price breaches the second support level.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
There are 713,549K outstanding shares of the company, which has a market capitalization of 7.49 billion. As of now, sales total 124,800 K while income totals 4,349 M. Its latest quarter income was 9,020 K while its last quarter net income were 169,380 K.
